Home > Insider Trading > K-V Pharmaceutical Co > Profile

K-V Pharmaceutical Co (KVA/KVB)

Market is closed

Sector: Pharmaceutical Preparations

Related Insiders

M Mahady Joseph, Director, 2014-03-05
J. Patrick Christmas, General Counsel, 2014-03-05
Steven Nielson, Director, 2014-03-05

M Mahady Joseph, Director, 2014-03-05
J. Patrick Christmas, General Counsel, 2014-03-05
Steven Nielson, Director, 2014-03-05
Joe Mcinnis, Director, 2014-03-05
S. Janet Vergis, Director, 2014-03-05
S Thomas Mchugh, Chief Financial Officer, 2014-03-05
M. James Goldfarb, Director, 2014-03-05
Gregory Norden, Director, 2014-03-05
J Greg Divis, Ceo And President, 2014-03-05
J Robert O'shea, Large Shareholder, 2013-11-20
L.p. Capital Point Silver, Large Shareholder, 2013-11-20
A Edward Mule, Large Shareholder, 2013-11-20
Eric Haron, Director, 2013-10-15
B. Jonathan Siegel, Director, 2013-10-04
Ana Stancic, Director, 2013-09-27
E Robert Baldini, Director, 2013-09-27
A. Mark Dow, Director, 2013-09-26
Smith Gregory Bentley, Director, 2013-09-26
S David Hermelin, Director, 2013-09-26
David Sidransky, Director, 2013-09-20
D Joseph Lehrer, Director, 2013-09-19
M Lawrence Robbins, Large Shareholder, 2013-08-07
Glenview Capital Management, Llc, Large Shareholder, 2013-08-07
Trust & Bank Financial Parkside, Large Shareholder, 2013-02-07
L Arnold Hermelin, Large Shareholder, 2011-03-08
Jeffrey Aronson, Large Shareholder, 2010-11-29
T Mark Gallogly, Large Shareholder, 2010-11-29
Centerbridge Special Credit Advisors, L.l.c., Large Shareholder, 2010-11-29
U.s. Healthcare Ii, L.l.c., Large Shareholder, 2010-11-29
U.s. Healthcare I, L.l.c., Large Shareholder, 2010-11-29
Centerbridge Partners, L.p., Large Shareholder, 2010-11-29
Centerbridge Partners Holdings, Llc, Large Shareholder, 2010-11-29
Centerbridge Credit Advisors, L.l.c., Large Shareholder, 2010-11-29
S Marc Hermelin, Large Shareholder, 2010-11-17
T. Mark Hartman, Pres. - Generics Division, 2010-10-22
R. John Sampson, Director, 2010-06-14
Stephen Stamp, Cfo, 2010-04-12
C. Janice Forsyth, Vp, Gen. Counsel & Secretary, 2010-01-20

Show All Insiders (38)

Hedge Fund Holdings

Filing Period:

No.	Hedge Fund	Shares	Value	Activity	% Port
1.	Greywolf Capital ManagementNOTE 2.500% 5/1 Jonathan Savitz	0	$0		0%
2.	Whitebox AdvisorsNOTE 2.500% 5/1 Andy Redleaf	0	$0		0%

Insider Trading: Purchases See All

Insider	Price	Amount	Relationship	Remaining Holdings	Date	Form 4
Silver	$46.50	25,000	Large Shareholder	2,023,883	2013-11-18	Filing
Silver	$44.50	50,000	Large Shareholder	1,998,883	2013-11-14	Filing
Silver	$42.75	57,162	Large Shareholder	1,948,883	2013-11-13	Filing
Silver	$40.00	150,000	Large Shareholder	1,715,721	2013-09-23	Filing
Glenview	$0.46	1,764,709	Large Shareholder	4,897,274	2013-08-06	Filing

Insider Trading: Sales See All

Insider	Price	Amount	Relationship	Remaining Holdings	Date	Form 4
Silver	$40.00	199,000	Large Shareholder	1,516,721	2013-09-26	Filing
Glenview	$0.46	1,764,709	Large Shareholder	4,897,274	2013-08-06	Filing
Hermelin	$10.37	5,000	Large Shareholder	289,179	2011-03-04	Filing
Hermelin	$10.35	5,000	Large Shareholder	294,179	2011-03-04	Filing
Hermelin	$10.33	3,800	Large Shareholder	299,179	2011-03-04	Filing